Among these, ITGB8, RELN, and SPP1 were the top tumor-promoting candidates significantly downregulated (FDR < 0.05) by YBX1 knockdown in the ECM-receptor interaction pathway (Table 3). Here, ITGB8 is linked to neoplasm.